Midline catheters for extracorporeal photopheresis in hematological patients

被引:2
|
作者
Marche, Bruno [1 ]
D'Arrigo, Sonia [2 ]
Annetta, Maria Giuseppina [2 ]
Musaro, Andrea [3 ]
Emoli, Alessandro [4 ]
Sica, Simona [1 ]
Piccirillo, Nicola [5 ]
Putzulu, Rossana [5 ]
De Paolis, Maria [5 ]
Bernoldi, Marco [5 ]
Pittiruti, Mauro [6 ]
机构
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dept Hematol, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dept Anesthesia & Intens Care, Largo Gemelli 8, I-00168 Rome, Italy
[3] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dept Oncol Gynecol, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dept Oncol, Rome, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Transfus Med Dept, Rome, Italy
[6] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dept Surg, Rome, Italy
关键词
Midline catheter; graft versus host disease; extracorporeal photopheresis; difficult venous access; ultrasound-guided;
D O I
10.1177/11297298211041450
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Introduction: Peripheral venous access for extracorporeal photopheresis (ECP) may be difficult in graft versus host disease (GVHD) patients, because of previous intravenous therapies and multiple peripheral cannulations; in this population of patients, ultrasound guided midline catheters may be an alternative option to central venous access. Methods: In this single-center, prospective preliminary study, we enrolled all consecutive patients with a diagnosis of GVHD and candidate to ECP, over a period of 10 months. We used inserted power injectable, non-valved, polyurethane, 20-25 cm single lumen midline catheters (MC). Results: Sixty-nine ECP procedures were carried out in six patients, using single-lumen MCs for outflow (5Fr in 74% and 4Fr in 26% of cases). For inflow, we used 5Fr or 4Fr MCs, or central venous access devices previously placed for other clinical reasons. There were no catheter-related complications during the entire period of ECP treatment. Mean outflow was significantly higher for 5Fr than for 4Fr MCs (35.8 +/- 7.3 vs 29.2 +/- 7.8 ml/min; p = 0.0008) and the procedure time was significantly shorter (92.9 +/- 9.2 vs 108 +/- 13.2 min; p < 0.0001). Conclusion: In GVHD patients, ECP can be performed efficiently and safely using single lumen polyurethane power injectable MCs. The best results are obtained with 5Fr rather than with 4Fr catheters. This strategy of venous access should be implemented in DIVA patients requiring ECP treatments, and probably also in other types of apheresis.
引用
收藏
页码:568 / 574
页数:7
相关论文
共 50 条
  • [41] Assessment of extracorporeal photopheresis related cell damage
    Samur, Bahadir M.
    Karakukcu, Cigdem
    Ozcan, Alper
    Unal, Ekrem
    Yilmaz, Ebru
    Karakukcu, Musa
    TRANSFUSION AND APHERESIS SCIENCE, 2022, 61 (06)
  • [42] Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
    Roberto, Crocchiolo
    Clara, Cesana
    Debora, Girgenti
    Giambattista, Bertani
    Claudia, Barba
    Giuseppa, Liga
    Ursula, Ferri
    Lara, Crucitti
    Giovanni, Grillo
    Silvano, Rossini
    Roberto, Cairoli
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [43] EXTRACORPOREAL PHOTOPHERESIS IN A RAT MODEL OF PULMONARY FIBROSIS
    Remund, Kaspar
    Rechsteiner, Thomas
    Guo, Zhongning
    Hofer, Markus
    Boehler, Annette
    EXPERIMENTAL LUNG RESEARCH, 2009, 35 (05) : 359 - 370
  • [44] Recent insights into extracorporeal photopheresis for graft-versus-host disease
    Del Fante, Claudia
    Perotti, Cesare
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (04) : 339 - 348
  • [45] Effects of extracorporeal photopheresis on survival in chronic graft versus host disease
    Kaya, Ahmet
    Kaya, Emin
    Kuku, Irfan
    Erkurt, Mehmet Ali
    Berber, Ilhami
    Bicim, Soykan
    Arslan, Suleymen
    Yagin, Fatma Hilal
    Uysal, Ayse
    MARMARA MEDICAL JOURNAL, 2024, 37 (03): : 358 - 365
  • [46] Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis
    Stables, GI
    Taylor, PC
    Highet, AS
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (04) : 781 - 783
  • [47] Therapeutic implications of extracorporeal photopheresis for rheumatic diseases
    Morgiel, Ewa
    Dybko, Jaroslaw
    Madej, Marta
    Mazur, Grzegorz
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2020, 74 : 391 - 398
  • [48] Factual reflections and recommendations on extracorporeal photopheresis in pediatrics
    Sniecinski, Irena
    Seghatchian, Jerard
    TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (02) : 118 - 122
  • [49] Impact of extracorporeal photopheresis on blood and coagulation parameters
    Gambichler, Thilo
    Chatzipantazi, Maria
    Stranzenbach, Rene
    Feldkamp, Alicia
    Susok, Laura
    DERMATOLOGIC THERAPY, 2022, 35 (05)
  • [50] Infectious risks in patients treated with extracorporeal photopheresis for graft-versus-host disease: A retrospective cohort study
    Thevenet, Ugo
    Daguenet, Elisabeth
    Beszera, Silvia-Maria
    Cornillon, Jerome
    Tavernier, Emmanuelle
    Schein, Flora
    Honeyman, Fressia
    Guyotat, Denis
    JOURNAL OF CLINICAL APHERESIS, 2022, 37 (01) : 106 - 116